Browsing publications by William Cunliffe

Newcastle AuthorsTitleYear
Dr Brian Shenton
William Cunliffe
Professor Thomas Lennard
Stat3 expression is a poor prognostic marker for invasive breast cancer2007
Dr Catherine Todhunter
Maria Price
Alison Sutherland-Craggs
Dr Peter Donaldson
William Cunliffe
et al.
CARD 15, smoking, and time to second operation in ileal Crohn's disease2005
William Cunliffe
Dr Nicholas Simpson
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne2005
William Cunliffe
Dr Nicholas Simpson
Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial2004
Fiona Girdler
Dr Ian Brotherick
William Cunliffe
Professor Thomas Lennard
Dr Brian Shenton
et al.
ER alpha and ER alpha exon5 expression in tamoxifen treated tumours2002
Dr Ian Brotherick
Susan Stamp
William Cunliffe
Dr Gail Higginbottom
Dr James Young
et al.
Neoadjuvant tamoxifen treatment and its effect on MUC1 expression in primary breast cancer2002
Dr Ian Brotherick
Susan Stamp
Fiona Girdler
William Cunliffe
Professor Thomas Lennard
et al.
The influence of tamoxifen treatment on E-cadherin expression in primary breast cancer2002
Fiona Girdler
Dr Ian Brotherick
William Cunliffe
Professor Thomas Lennard
Dr James Young
et al.
Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS22002
Adillah Binti Yusof
Dr Ian Brotherick
William Cunliffe
Professor Thomas Lennard
Dr James Young
et al.
ER alpha and ER alpha Delta 5 expression in tamoxifen-treated breast tumours.2001
Dr Craig Dixon
Dr Amanda Ray
Sion Phillips
William Cunliffe
Dr Simon Meggitt
et al.
Expression, candidate gene, and population studies of the melanocortin 5 receptor2001
12